Search - tctmd.com

Displaying 1 - 20 of 40

Sort: Relevancy | Date

News Daily News

Oral GLP-1s Provide Benefit in HF Patients: SOUL Subanalysis

L.A. McKeown

February 06, 2026

News Daily News

AHA/ASA Release New Comprehensive Acute Ischemic Stroke Guideline

Todd Neale

January 29, 2026

News Daily News

FDA Approves Lerodalcibep for Adults With Hypercholesterolemia

Yael L. Maxwell

December 15, 2025

News Daily News

Weight-Loss Drug MariTide Gains Momentum in Phase II Trial

Caitlin E. Cox

June 25, 2025

News Daily News

Amylin Analogue Boosts Weight Loss When Added to GLP-1

L.A. McKeown

June 24, 2025

News Daily News

Inclisiran Plus Usual Care Improves LDL Control in ACS: VICTORION-INCEPTION

Michael O'Riordan

June 04, 2025

News Daily News

Inclisiran Effective as Monotherapy for Lower-Risk Primary Prevention

Michael O'Riordan

May 07, 2025

News Daily News

Vutrisiran, With the FDA’s Sign-off, Joins the Fray for ATTR-CM

Caitlin E. Cox

March 21, 2025

News Daily News

Top General Cardiology and Prevention News of 2024

Caitlin E. Cox

December 30, 2024

News Daily News

Lp(a) Still Low Almost 1 Year After Last Olpasiran Injection: OCEAN(a)-DOSE

Yael L. Maxwell

August 19, 2024

News Daily News

Infective Endocarditis in Opioid Users: Care Must Go Beyond the Heart

Caitlin E. Cox

February 26, 2024

News Daily News

Injectable Semaglutide Shortage Forces Physicians to Pivot

Todd Neale

February 05, 2024

News Daily News

Infective Endocarditis Deaths Rise as Opioid Crisis Deepens

Caitlin E. Cox

December 14, 2023

News Daily News

No Safety Concerns Seen With Inclisiran in Large ORION Analysis

Michael O'Riordan

December 06, 2023

News Daily News

Hormonal Birth Control, NSAID Use Together Linked to VTE

Caitlin E. Cox

September 11, 2023

News Daily News

Sustained LDL-Cholesterol Reductions With Inclisiran: ORION-3

Michael O'Riordan

January 16, 2023

News Daily News

SURMOUNT-1: Tirzepatide Drastically Reduces Weight in Obese Patients

L.A. McKeown

June 09, 2022

News Daily News

TCTMD’s Top 10 Most Popular Stories for December 2021

Caitlin E. Cox

December 29, 2021

News Daily News

Switching to Tenecteplase for Stroke Thrombolysis May Boost Outcomes

Todd Neale

September 09, 2021

News Daily News

OMT Boosts Survival in Revascularized Patients at 10 Years

Michael O'Riordan

June 29, 2021

Advertisement

Oral GLP-1s Provide Benefit in HF Patients: SOUL Subanalysis

AHA/ASA Release New Comprehensive Acute Ischemic Stroke Guideline

FDA Approves Lerodalcibep for Adults With Hypercholesterolemia

Weight-Loss Drug MariTide Gains Momentum in Phase II Trial

Amylin Analogue Boosts Weight Loss When Added to GLP-1

Inclisiran Plus Usual Care Improves LDL Control in ACS: VICTORION-INCEPTION

Inclisiran Effective as Monotherapy for Lower-Risk Primary Prevention

Vutrisiran, With the FDA’s Sign-off, Joins the Fray for ATTR-CM

Top General Cardiology and Prevention News of 2024

Lp(a) Still Low Almost 1 Year After Last Olpasiran Injection: OCEAN(a)-DOSE

Infective Endocarditis in Opioid Users: Care Must Go Beyond the Heart

Injectable Semaglutide Shortage Forces Physicians to Pivot

Infective Endocarditis Deaths Rise as Opioid Crisis Deepens

No Safety Concerns Seen With Inclisiran in Large ORION Analysis

Hormonal Birth Control, NSAID Use Together Linked to VTE

Sustained LDL-Cholesterol Reductions With Inclisiran: ORION-3

SURMOUNT-1: Tirzepatide Drastically Reduces Weight in Obese Patients

TCTMD’s Top 10 Most Popular Stories for December 2021

Switching to Tenecteplase for Stroke Thrombolysis May Boost Outcomes

OMT Boosts Survival in Revascularized Patients at 10 Years

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content